2018
DOI: 10.1002/cpdd.444
|View full text |Cite
|
Sign up to set email alerts
|

Risk Factor for Diabetes Mellitus and High Blood Glucose With HMG‐CoA Reductase Inhibitors Using a Postmarketing Surveillance Database in Japan

Abstract: To investigate whether 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (statin) use is associated with an increased risk of diabetes mellitus and hyperglycemia, we performed a nested case-control study using a postmarketing surveillance database in Japan. The database cohort included 26,849 cases of statin use and 5308 cases of other lipid-lowering drug use in patients with hyperlipidemia. Participants received at least 1 type of statin, had a clear medication history of statin use, and had no compli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…In addition, long-term statin use on patients at high risk of diabetes onset causes significantly more diabetes onset 75) . According to post-marketing surveillance data, fatty liver and hyperuricemia are risk factors for diabetes onset 76) .…”
Section: Resultsmentioning
confidence: 99%
“…In addition, long-term statin use on patients at high risk of diabetes onset causes significantly more diabetes onset 75) . According to post-marketing surveillance data, fatty liver and hyperuricemia are risk factors for diabetes onset 76) .…”
Section: Resultsmentioning
confidence: 99%